Lallemand completes Evolva acquisition to bolster health and flavor businesses

08 Jan 2024 — Industrial biotechnology leader Lallemand has acquired Swiss biotechnology firm Evolva for a reported CHF20 million (∼US$23.5 million) through its Swiss affiliate Danstar Ferment. Lallemand expects to capitalize on Evolva’s precision fermentation capabilities through this deal. 

The transaction, which was originally announced to the Swiss Stock Exchange on November 21, 2023, was approved by Evolva shareholders at an extraordinary general meeting on December 21, 2023.